Page 45 - Advanced echocardiography in characterization and management of patients with secondary mitral regurgitation
P. 45

H, Maalouf J, Nkomo V, Thapa P, Enriquez-Sarano M. Outcome and undertreatment of mitral regurgi- tation: a community cohort study. Lancet 2018;391(10124):960-969.
20. Werner N, Puls M, Baldus S, Lubos E, Bekeredjian R, Sievert H, Schofer J, Kuck KH, Möllmann H, Hehrlein C, Nickenig G, Boekstegers P, Ouarrak T, Senges J, Zahn R. Gender-related differences in patients undergoing transcatheter mitral valve inter- ventions in clinical practice: 1-year results from the German TRAMI registry. Catheter Cardiovasc Interv 2020;95(4):819-829.
21. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Hor- vath KA, Geller NL, Miller MA, Woo YJ, D’Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O’Gara PT, Michler RE, Kron IL. Mitral-valve re- pair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014;370(1):23-32.
22. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefevre T, Piot C, Rouleau F, Car- rie D, Nejjari M, Ohlmann P, Lecler- cq F, Saint Etienne C, Teiger E, Ler- oux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Ar- moiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N. Percutane- ous Repair or Medical Treatment for
Secondary Mitral Regurgitation. N
Engl J Med 2018.
23. Stone GW, Lindenfeld J, Abraham
WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarem- bock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ. Tran- scatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 2018.
24. Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanows- ki M, Verboven Y, Tavazzi L. Predict- ing the long-term effects of cardiac resynchronization therapy on mor- tality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchro- nization in Heart Failure) Trial. J Am Coll Cardiol 2008;52(6):438-45.
25. Ferreira JP, Duarte K, McMurray JJV, Pitt B, van Veldhuisen DJ, Vincent J, Ahmad T, Tromp J, Rossignol P, Zannad F. Data-Driven Approach to Identify Subgroups of Heart Fail- ure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Re- sponse Patterns. Circ Heart Fail 2018;11(7):e004926.
26. Kloosterman M, van Stipdonk AMW, ter Horst I, Rienstra M, Van Gelder IC, Vos MA, Prinzen FW, Meine M, Vernooy K, Maass AH. Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardi- ac resynchronization therapy. ESC Heart Failure 2020;7(2):645-653.
43
 Ch 2






















































































   43   44   45   46   47